Phase II Study of RAD001 monotherapy in Patients With Unresectable Pheochromocytoma or Extra-adrenal Paraganglioma or Non-functioning Carcinoid.
Phase of Trial: Phase II
Latest Information Update: 19 May 2015
At a glance
- Drugs Everolimus (Primary)
- Indications Carcinoid tumour; Paraganglioma; Pheochromocytoma
- Focus Therapeutic Use
- Acronyms PheoCarcRAD001
- 19 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Jul 2010 New trial record